Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial
Felix Mahfoud(University of Basel), Sebastian Kelle(Deutsches Herzzentrum München), Michael Böhm(Saarland University), Murray Esler(Baker Heart and Diabetes Institute), Ernst Wellnhofer(Berlin Heart (Germany)), Stephan Dreysse(Deutsches Herzzentrum der Charité), Markus P. Schlaich(The University of Western Australia), Jan-Hendrik Hassel(Deutsches Herzzentrum der Charité), Daniel J. Urban(National Institutes of Health), Dominik Linz(University of Copenhagen), Adelina Doltra(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Peter Fries(Universitätsklinikum des Saarlandes), Arno Buecker(Universitätsklinikum des Saarlandes), Christopher Schneeweis(Deutsches Herzzentrum der Charité), Günther Schneider(Universitätsklinikum des Saarlandes), Philipp Stawowy(University of California, Los Angeles), Eckart Fleck(Deutsches Herzzentrum der Charité), Desiree Claudia Elisabeth Teller(Deutsches Herzzentrum der Charité)
Cited by 160
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k